Ramkripa Raghavan1, Anne W Riley1, Heather Volk2, Deanna Caruso1, Lynn Hironaka3, Laura Sices3, Xiumei Hong1, Guoying Wang1, Yuelong Ji1, Martha Brucato4, Anastacia Wahl3, Tom Stivers3, Colleen Pearson3, Barry Zuckerman3, Elizabeth A Stuart2,5, Rebecca Landa6, M Daniele Fallin2, Xiaobin Wang1,7. 1. Center on the Early Life Origins of Disease, Department of Population, Family and Reproductive Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD. 2. Wendy Klag Center for Autism and Developmental Disabilities & Department of Mental Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD. 3. Department of Pediatrics, Boston University School of Medicine and Boston Medical Center, Boston, MA. 4. Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD. 5. Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD. 6. Kennedy Krieger Institute, Baltimore, MD. 7. Division of General Pediatrics & Adolescent Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD.
Abstract
BACKGROUND: To examine the prospective association between multivitamin supplementation during pregnancy and biomarker measures of maternal plasma folate and vitamin B12 levels at birth and child's Autism Spectrum Disorder (ASD) risk. METHODS: This report included 1257 mother-child pairs, who were recruited at birth and prospectively followed through childhood at the Boston Medical Center. ASD was defined from diagnostic codes in electronic medical records. Maternal multivitamin supplementation was assessed via questionnaire interview; maternal plasma folate and B12 were measured from samples taken 2-3 days after birth. RESULTS: Moderate (3-5 times/week) self-reported supplementation during pregnancy was associated with decreased risk of ASD, consistent with previous findings. Using this as the reference group, low (≤2 times/week) and high (>5 times/week) supplementation was associated with increased risk of ASD. Very high levels of maternal plasma folate at birth (≥60.3 nmol/L) had 2.5 times increased risk of ASD [95% confidence interval (CI) 1.3, 4.6] compared to folate levels in the middle 80th percentile, after adjusting for covariates including MTHFR genotype. Similarly, very high B12 (≥536.8 pmol/L) showed 2.5 times increased risk (95% CI 1.4, 4.5). CONCLUSION: There was a 'U shaped' relationship between maternal multivitamin supplementation frequency and ASD risk. Extremely high maternal plasma folate and B12 levels at birth were associated with ASD risk. This hypothesis-generating study does not question the importance of consuming adequate folic acid and vitamin B12 during pregnancy; rather, raises new questions about the impact of extremely elevated levels of plasma folate and B12 exposure in-utero on early brain development.
BACKGROUND: To examine the prospective association between multivitamin supplementation during pregnancy and biomarker measures of maternal plasma folate and vitamin B12 levels at birth and child's Autism Spectrum Disorder (ASD) risk. METHODS: This report included 1257 mother-child pairs, who were recruited at birth and prospectively followed through childhood at the Boston Medical Center. ASD was defined from diagnostic codes in electronic medical records. Maternal multivitamin supplementation was assessed via questionnaire interview; maternal plasma folate and B12 were measured from samples taken 2-3 days after birth. RESULTS: Moderate (3-5 times/week) self-reported supplementation during pregnancy was associated with decreased risk of ASD, consistent with previous findings. Using this as the reference group, low (≤2 times/week) and high (>5 times/week) supplementation was associated with increased risk of ASD. Very high levels of maternal plasma folate at birth (≥60.3 nmol/L) had 2.5 times increased risk of ASD [95% confidence interval (CI) 1.3, 4.6] compared to folate levels in the middle 80th percentile, after adjusting for covariates including MTHFR genotype. Similarly, very high B12 (≥536.8 pmol/L) showed 2.5 times increased risk (95% CI 1.4, 4.5). CONCLUSION: There was a 'U shaped' relationship between maternal multivitamin supplementation frequency and ASD risk. Extremely high maternal plasma folate and B12 levels at birth were associated with ASD risk. This hypothesis-generating study does not question the importance of consuming adequate folic acid and vitamin B12 during pregnancy; rather, raises new questions about the impact of extremely elevated levels of plasma folate and B12 exposure in-utero on early brain development.
Authors: Christine M Pfeiffer; Jeffery P Hughes; David A Lacher; Regan L Bailey; R J Berry; Mindy Zhang; Elizabeth A Yetley; Jeanne I Rader; Christopher T Sempos; Clifford L Johnson Journal: J Nutr Date: 2012-03-21 Impact factor: 4.798
Authors: Karen E Christensen; Leonie G Mikael; Kit-Yi Leung; Nancy Lévesque; Liyuan Deng; Qing Wu; Olga V Malysheva; Ana Best; Marie A Caudill; Nicholas D E Greene; Rima Rozen Journal: Am J Clin Nutr Date: 2015-01-07 Impact factor: 7.045
Authors: Yiting Zhang; Nathaniel W Hodgson; Malav S Trivedi; Hamid M Abdolmaleky; Margot Fournier; Michel Cuenod; Kim Quang Do; Richard C Deth Journal: PLoS One Date: 2016-01-22 Impact factor: 3.240
Authors: Nicole Yadon; Amy Owen; Patricia Cakora; Angela Bustamante; April Hall-South; Nuri Smith; Michael R Felder; Paul B Vrana; Kimberly R Shorter Journal: Physiol Behav Date: 2019-07-09
Authors: Olga Egorova; Robin Myte; Jörn Schneede; Bruno Hägglöf; Sven Bölte; Erik Domellöf; Barbro Ivars A'roch; Fredrik Elgh; Per Magne Ueland; Sven-Arne Silfverdal Journal: Mol Autism Date: 2020-01-16 Impact factor: 7.509
Authors: Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk Journal: Bipolar Disord Date: 2018-03-14 Impact factor: 6.744
Authors: Ramkripa Raghavan; M Daniele Fallin; Xiumei Hong; Guoying Wang; Yuelong Ji; Elizabeth A Stuart; David Paige; Xiaobin Wang Journal: J Autism Dev Disord Date: 2019-01